Concordia International Corp Company Profile (TSE:CXR)

About Concordia International Corp (CXR)

Concordia International Corp logoConcordia International Corp, formerly Concordia Healthcare Corp, is a Canada-based pharmaceutical company. The Company, through subsidiaries, owns a portfolio of branded and generic prescription products. Its activities are divided into four segments: Concordia North America, includes sales of pharmaceutical products, such as Donnatal for the treatment of irritable bowel syndrome, Zonegran for the treatment of partial seizures in adults with epilepsy and Nilandron for the treatment of metastatic prostate cancer; Concordia International, includes a portfolio of branded and generic products that are sold to wholesalers, hospitals and pharmacies in over 100 countries, and focuses on acquisition, licensing and development of off-patent prescription medicines; Orphan Drugs, includes Photofrin, which is for the treatment of certain forms of rare cancer, and Corporate cost centre, includes centralized costs incurred by the Company.

Industry, Sector and Symbol:
  • Sector: N/A
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: TSE
  • Symbol: CXR
  • CUSIP: N/A
Key Metrics:
  • Previous Close: $2.16
  • 50 Day Moving Average: $2.91
  • 200 Day Moving Average: $3.89
  • 52-Week Range: C$2.05 - C$28.35
  • Trailing P/E Ratio: N/A
  • P/E Growth: 0.00
  • Market Cap: $110.35M
  • Outstanding Shares: 51,089,000

Analyst Ratings

Consensus Ratings for Concordia International Corp (TSE:CXR) (?)
Ratings Breakdown: 5 Sell Ratings, 1 Hold Rating
Consensus Rating:Sell (Score: 1.17)
Consensus Price Target: C$14.83

Analysts' Ratings History for Concordia International Corp (TSE:CXR)
DateFirmActionRatingPrice TargetDetails
3/16/2017ScotiabankReiterated RatingUnderperformView Rating Details
2/9/2017TD SecuritiesDowngradeHold -> ReduceView Rating Details
12/8/2016Royal Bank of CanadaDowngradeSector Perform -> UnderperformView Rating Details
11/7/2016Bloom BurtonDowngradeHold -> SellView Rating Details
8/15/2016Goldman Sachs Group IncLower Price TargetC$34.00 -> C$17.00View Rating Details
8/15/2016CIBCDowngradeSector Perform -> UnderperformView Rating Details
3/21/2016Dundee SecuritiesLower Price TargetC$62.00 -> C$60.00View Rating Details
12/3/2015MackieDowngradeHoldView Rating Details
9/9/2015Canaccord GenuityBoost Price TargetC$95.00 -> C$100.00View Rating Details
5/19/2015LaurentianBoost Price TargetBuyC$101.50 -> C$106.00View Rating Details
(Data available from 3/29/2015 forward)


Earnings History for Concordia International Corp (TSE:CXR)
Earnings by Quarter for Concordia International Corp (TSE:CXR)
Earnings History by Quarter for Concordia International Corp (TSE:CXR)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/13/2015Q2$1.06$1.04ViewListenView Earnings Details
8/14/2014$0.19($0.03)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Concordia International Corp (TSE:CXR)
Current Year EPS Consensus Estimate: $1.50 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161$1.86$1.86$1.86
Q2 20161$2.11$2.11$2.11
Q3 20161$2.19$2.19$2.19
Q4 20161$2.22$2.22$2.22
(Data provided by Zacks Investment Research)


Dividend History by Quarter for Concordia International Corp (TSE:CXR)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading and Institutional Ownership History for Concordia International Corp (TSE:CXR)
Insider Trades by Quarter for Concordia International Corp (TSE:CXR)
Insider Trades by Quarter for Concordia International Corp (TSE:CXR)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
2/1/2016Mark Laurence ThompsonDirectorBuy60C$28.77C$1,726.20
11/17/2015Rochelle FuhrmannDirectorBuy2,000C$31.67C$63,340.00
11/17/2015Wayne Walter KreppnerInsiderBuy3,000C$43.67C$131,010.00
11/16/2015Mark Laurence ThompsonDirectorBuy23,150C$43.36C$1,003,702.98
10/27/2015Edward BorkowskiDirectorBuy4,000C$30.43C$121,720.00
7/23/2015Jordan KupinskyDirectorSell43,000C$103.70C$4,459,272.00
7/17/2015Wayne Walter KreppnerInsiderSell4,800C$103.00C$494,400.00
7/3/2015Jordan KupinskyDirectorSell10,800C$92.21C$995,884.20
7/2/2015Jordan KupinskyDirectorSell45,900C$92.05C$4,224,934.35
6/26/2015Robert Steven AltmanInsiderSell62,500C$93.93C$5,870,893.75
6/22/2015John-Michel HussDirectorSell5,000C$92.00C$460,000.00
6/19/2015John-Michel HussDirectorSell4,300C$90.00C$387,000.00
6/11/2015John-Michel HussDirectorSell4,500C$90.02C$405,076.50
5/27/2015Saldanha Adrian DeInsiderBuy1,000C$80.61C$80,610.00
5/19/2015Adeel AhmadInsiderSell25,000C$83.80C$2,094,890.00
10/31/2014James Christopher ReebalsDirectorSell7,500C$37.25C$279,360.75
10/30/2014James Christopher ReebalsDirectorSell7,500C$37.06C$277,926.75
10/29/2014James Christopher ReebalsDirectorSell5,000C$37.07C$185,336.50
(Data available from 1/1/2013 forward)


Headline Trends for Concordia International Corp (TSE:CXR)
Latest Headlines for Concordia International Corp (TSE:CXR)


Frequently Asked Questions for Concordia International Corp (TSE:CXR)

What is Concordia International Corp's stock symbol?

Concordia International Corp trades on the Tornton Stock Exchange (TSX) under the ticker symbol "CXR."

How often does Concordia International Corp pay dividends? What is the dividend yield for Concordia International Corp?

Concordia International Corp declared a quarterly dividend on Wednesday, July 13th. Shareholders of record on Friday, July 29th will be given a dividend of 0.075 per share on Friday, July 29th. This represents a $0.30 annualized dividend and a yield of 13.89%. The ex-dividend date is Wednesday, July 13th.

How were Concordia International Corp's earnings last quarter?

Concordia International Corp (TSE:CXR) announced its quarterly earnings results on Thursday, August, 13th. The company reported $1.04 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.06 by $0.02.

When will Concordia International Corp make its next earnings announcement?

Concordia International Corp is scheduled to release their next quarterly earnings announcement on Thursday, May, 11th 2017.

Where is Concordia International Corp's stock going? Where will Concordia International Corp's stock price be in 2017?

6 brokerages have issued 1 year target prices for Concordia International Corp's stock. Their predictions range from C$13.50 to C$17.00. On average, they expect Concordia International Corp's share price to reach C$14.83 in the next year.

How do I buy Concordia International Corp stock?

Shares of Concordia International Corp and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.

How much does a share of Concordia International Corp stock cost?

One share of Concordia International Corp stock can currently be purchased for approximately C$2.16.

Concordia International Corp (CXR) Chart for Wednesday, March, 29, 2017

This page was last updated on 3/29/2017 by Staff